🇺🇸 FDA
Pipeline program

Ramelteon

01-02-TL-375-021

Approved small_molecule completed

Quick answer

Ramelteon for Chronic Insomnia is a Approved program (small_molecule) at Takeda with 7 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Chronic Insomnia
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials